3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
103
Lymphoma
68
Lymphoma, Large B-Cell, Diffuse
49
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Sarcoma
33
Lymphoma, Non-Hodgkin
29
Hodgkin Disease
28
Leukemia
23
Burkitt Lymphoma
22
Neoplasms
19
Lymphoma, Mantle-Cell
18
Triple Negative Breast Neoplasms
15
Multiple Myeloma
15
Lymphoma, Follicular
15
Lymphoma, B-Cell
14
Lymphoma, Large-Cell, Anaplastic
12
Carcinoma, Hepatocellular
12
Breast Neoplasms, Male
11
Neuroblastoma
10
Recurrence
9
Ovarian Neoplasms
9
Neoplasm Metastasis
9
Inflammatory Breast Neoplasms
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, T-Cell
8
Osteosarcoma
7
Fallopian Tube Neoplasms
7
Urinary Bladder Neoplasms
6
Liposarcoma
6
Interventions
Vincristine
8
Magnetic Resonance Spectroscopy
8
Cyclophosphamide
7
Cisplatin
6
X-Rays
5
Specimen Handling
5
Radiotherapy
5
Phantoms, Imaging
5
Irinotecan
5
Carboplatin
5
Temozolomide
4
Radiation
4
Platinum
4
Nuclear Medicine Department, Hospital
4
Lomustine
4
palbociclib
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Etoposide
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
sonidegib
2
selpercatinib
2
olaparib
2
merphos
2
larotrectinib
2
ivosidenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Medulloblastoma
×
Doxorubicin
×
Clear all
No trials found.